| Lightcalls.com |
|
|
![]() |
Feathers were ruffl when John McKin...Feathers were ruffl when John McKinley, director of the just discovered England Research Institute in Boston, announced not long ago that most estrogen replacement therapy for menopause is unnecessary. McKinley, who overturn orthodox researchers and conventional medical doctors, based his statement forward the Massachusetts Women's Health meditation the largest of its kind, involving a random sampling of 2500 women who have been followed since they were ages 45 to 55 in 1981 His research also indicated little or no relationship between menopause and depression. Conventional medical practitioners favor estrogen replacement therapy (ERT) maintaining that it helps to guard against heart attacks and bone-thinning (osteoporosis) and attendant hip fractures. Common menopausal symptoms Many of the following symptoms drive menopausal women to solicit ERT: backaches, bladder problems, breathing difficulties, burning urine, chronic itching, dizziness (vertigo), fatigue, heart palpitations, headaches, irascible flashes, irritability, mood swings, nervousness, ringing in ears (tinnitus), rest disturbances (i.e., insomnia), vaginal hardening, and, among others, water retention. Medically, of the like kind symptoms arise because the ovary no longer separate s sufficient female hormone. Although estrogen helps women secure relief from these symptoms, there is near danger connected with such medication: a risk of developing endometrial and breast cancer. For this reason, progesterone was added to estrogen therapy, ostensibly making this medication safer. Orthodox researchers and doctors be stirred that the gain is worth the risk. And each woman on the verge of making a decision for or against must balance the gain against the risk. Several years ago, Kenneth A. Morhain, an obstetrician at Wright State University sect of Medicine in Dayton, Ohio, revealed consequence s of his study: that united form of hormone therapy may cause a thickening of the endometrium, the lining of the uterus. Findings of this kind fired up the endometrial cancer scare in the mid-1970s. Since then, physicians prescribing one as well as the other estrogen and progesterone claim this combination reckoners abnormal endometrial growth. However, on the same level one-a-day pills of estrogen and progesterone may contribute to endometrial thickening in near instances, states Morhain. It is important to learn to what degree to cope with stress. Mind and emotions can negatively or positively influence natural ends such as menopause. Some natural means of improving symptoms are to avoid coffee alcohol and smoking and to walk for at least a half hour three to four times weekly. Herbal remedies also are ofttimes helpful. One of the chiefly effective for menopause is black cohosh (Cimicifuga racemosa) which was used for this final cause in Europe as long ago as the 18th century In Herbal Tonic Therapies (Keats Publishing, Inc.), Daniel B Mowrey PhD writes: "Black cohosh was introduced to American medicine by the agency of the Indians, who called it Squaw parent in reference to one of its general uses, the treatment of uterine disorders." One cogitation reveals an improvement of symptoms after use of black cohosh tincture A German researcher named H Stolze mentions a reflection of menopausal women to whom. 40 globules of black cohosh tincture were administered pair times daily for from six to eight weeks. Within four weeks, 80 percent of the women showed improvement in menopausal symptoms, with an reporting that all symptoms were gone Here is a list of about of the studies' results: Hot flashes disappeared in 433 percent of patients. Profuse sweating disappeared in 499 percent Headaches were relieved in 457 percent Dizziness disappeared in 516 percent Sleeplessnes no longer plagued 461 percent Heart palpitations were gone in 546 percent of the cases. Ringing in the ears (tinnitus) stopped in 548 percent Black cohosh has been an overwhelmingly popular botanical complement throughout Europe for the past 40 years. As with many plant-based medicines which date back sum of two units to three centuries, black cohosh has no reported side effects REFERENCES Eron C "Life Change: What do Women Want?," Science recents July 2,1988. "Menopause Doubted as Depression Cause," United Pres International, May 5 1988 Mowrey Daniel B PhD Herbal Tonic Therapies. of recent origin Canaan, Conn.: Keats Publishing, Inc., 1993 Schaper and Bruner "Plant-based Gynecological Agent," Scientific pamphlet Germany, undated. COPYRIGHT 1996 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |